Basic Information
| ID | DRAMP21006 |
|---|
| Sequence | KCRRLCYRQRCVTYCRGR |
|---|
| Length | 18 |
|---|
| Name | [G1K, K8R]cGm (Derived from Gm) |
|---|
| Source | Synthetic construct |
|---|
| Activity | Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor |
|---|
| Pathogen | [Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=2 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=0.5-1 μM), Escherichia coli CGSC 5167 (MIC<0.015 μM), Klebsiella pneumoniae ATCC 700603 (MIC=8 μM), Acinetobacter baumannii ATCC 19606 (MIC=1-2 μM), Pseudomonas aeruginosa ATCC 27853 (MIC<0.25 μM), Helicobacter pylori ATCC 43504 (MIC>80 μM);##Fungi : Candida albicans ATCC 90028 (MIC=2 μM), Cryptococcus neoformans ATCC 208821 (MIC=0.125-0.25 μM) |
|---|
| Hemolytic Activity | [Ref.28741926] 0% hemolysis at 0.5 μM , 2.5% hemolysis at 0.6 μM , 20% hemolysis at 8 μM , 43.3-56.9% hemolysis at 64 μM , 50% hemolysis at 100 μM against human red blood cells |
|---|
| Cytotoxicity | [Ref.28741926] CC50 = 19.5 ± 0.5 μM against CRL-1739, CC50 = 1.7 ± 0.1 μM against MM96L, CC50 = 9.0 ± 0.5 μM against HFF-1, CC50 = 44.2 ± 2.2μM against HeLa, CC50 = 6.7 ± 0.7 μM against MCF-7, CC50 = 2.1 ± 0.2 μM against K-562, CC50 = 9.0 ± 1.1μM against HL-60;CC50=5.1 ± 0.3μM against PBMCs. |
|---|
| N-terminal Modification | No specific N-terminal |
|---|
| C-terminal Modification | No specific C-terminal |
|---|
| Linear/Cyclic/Branched | Cyclic |
|---|
| Uniprot |
|
|---|
| PDB |
|
|---|
| 3D View | |
|---|
| PDB Download | Download PDB Predicted by Alphafold2 |
|---|
| PubMed ID | 28741926 |
|---|
